Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 11, 2009
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
Meng-Lei Zhu, Natasha Kyprianou
Endocrine-Related Cancer
|
August 1, 2008
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells
Meng-Lei Zhu, Natasha Kyprianou
Virchows Archiv : an International Journal of Pathology
|
June 22, 2018
Comparison of targeted next generation sequencing (NGS) versus isolated BRAF V600E analysis in patients with metastatic melanoma
Meng-Lei Zhu, Lan Zhou, Navid Sadri
Brain Research
|
May 20, 2006
Prestin is expressed on the whole outer hair cell basolateral surface
Ning Yu, Meng-Lei Zhu, Hong-Bo Zhao
Cancer Research
|
February 2, 2013
Aire deficiency promotes TRP-1-specific immune rejection of melanoma
Meng-Lei Zhu, Anil Nagavalli, Maureen A Su
Thrombosis Research
|
December 8, 2020
Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura
Meng-Lei Zhu, Hollie M Reeves, Robert W Maitta
Cytokine
|
March 16, 2004
Molecular cloning and characterization of a novel rat CXC chemokine, rPBP, the homologue of human and mouse PBP
Wen-Xian Fu, Meng-Lei Zhu, Shun-You Gong, et al.
The Prostate
|
January 1, 2008
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells
Meng-Lei Zhu, James V Partin, Elizabeth M Bruckheimer, et al.
Thrombosis Research
|
November 29, 2019
Non-O blood group thrombotic thrombocytopenic purpura patients take longer to recover as measured by number of therapeutic plasma exchanges needed for platelet recovery
Mohadese Behtaj, Meng-Lei Zhu, Cassiana E Bittencourt, et al.
Cancer Research
|
September 3, 2010
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer
Meng-Lei Zhu, Craig M Horbinski, Mark Garzotto, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 11, 2009
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
Meng-Lei Zhu, Natasha Kyprianou
Endocrine-Related Cancer
|
August 1, 2008
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells
Meng-Lei Zhu, Natasha Kyprianou
Virchows Archiv : an International Journal of Pathology
|
June 22, 2018
Comparison of targeted next generation sequencing (NGS) versus isolated BRAF V600E analysis in patients with metastatic melanoma
Meng-Lei Zhu, Lan Zhou, Navid Sadri
Brain Research
|
May 20, 2006
Prestin is expressed on the whole outer hair cell basolateral surface
Ning Yu, Meng-Lei Zhu, Hong-Bo Zhao
Cancer Research
|
February 2, 2013
Aire deficiency promotes TRP-1-specific immune rejection of melanoma
Meng-Lei Zhu, Anil Nagavalli, Maureen A Su
Thrombosis Research
|
December 8, 2020
Immature platelet dynamics correlate with ADAMTS13 deficiency and predict therapy response in immune-mediated thrombotic thrombocytopenic purpura
Meng-Lei Zhu, Hollie M Reeves, Robert W Maitta
Cytokine
|
March 16, 2004
Molecular cloning and characterization of a novel rat CXC chemokine, rPBP, the homologue of human and mouse PBP
Wen-Xian Fu, Meng-Lei Zhu, Shun-You Gong, et al.
The Prostate
|
January 1, 2008
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells
Meng-Lei Zhu, James V Partin, Elizabeth M Bruckheimer, et al.
Thrombosis Research
|
November 29, 2019
Non-O blood group thrombotic thrombocytopenic purpura patients take longer to recover as measured by number of therapeutic plasma exchanges needed for platelet recovery
Mohadese Behtaj, Meng-Lei Zhu, Cassiana E Bittencourt, et al.
Cancer Research
|
September 3, 2010
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer
Meng-Lei Zhu, Craig M Horbinski, Mark Garzotto, et al.
Page
of 2